Concentric Medical focuses on catheter-based treatment of ischemic stroke, hypervascularized tumors and hemorrhagic stroke, otherwise known as cerebral aneurysm. The company is currently developing several proprietary device systems: the Merci™ Clot Retriever, indicated for clot removal; Embolic Pearls™ for embolic therapy of hypervascularized tumors; and embolic coil systems for the treatment of cerebral aneurysms. Concentric Medical, Inc. offers practical, breakthrough devices for what we believe is the greatest opportunity in the field of Interventional Neuroradiology. Concentric is working to develop products which are designed to enable physicians to simply and effectively treat ischemic stroke by removing thrombus from the cerebral vasculature.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 09/30/05 | Series C | 12.9M | Stefan Glaenzer, Alex Zubillaga, Austral Capital, COPEC-UC, RWE Innogy, TVM Capital, Sofinnova Partners, Northzone Ventures, Viking Ventures, SINTEF, VanEdge Capital, Sequoia Ventures | Unknown |
| 01/01/09 | Series D | 15M | Unknown |